Salivary LncRNA As a Potential Marker for Oral Squamous Cell Carcinoma Diagnosis
Overview
Authors
Affiliations
Oral squamous cell carcinoma (OSCC) is a common and lethal malignancy. Thus, improvement in current knowledge of molecular changes associated with OSCC is urgently needed to explore novel avenues of diagnostics and treatment of this disease. While aberrant expression of long non‑coding RNAs (lncRNAs) has been functionally associated with certain types of cancer, including lung, breast and prostate carcinomas, their expression pattern and biological relevance in OSCC is currently unknown. In the present study, the relative abundance of a collection of lncRNAs in tissue or saliva samples from OSCC patients was investigated. It was shown that subsets of lncRNAs are expressed across non‑tumor, tumor and metastatic tissue samples. Some detected lncRNAs were shown to be aberrantly expressed in cases of oral cancer and metastasis. Moreover, whole saliva contained a detectable amount of some lncRNAs, which appeared to be potential markers for OSCC. These findings suggest that the detection of lncRNAs in saliva may be used as a noninvasive and rapid diagnostic tool for the diagnosis of oral cancer.
Long non-coding RNA involved in the carcinogenesis of human female cancer - a comprehensive review.
Afroze N, Sundaram M, Haque S, Hussain A Discov Oncol. 2025; 16(1):122.
PMID: 39912983 PMC: 11803034. DOI: 10.1007/s12672-025-01848-1.
Diagnostics and Therapy for Malignant Tumors.
Tsai C, Wang C, Chang H, Chang P, Chang C, Chu T Biomedicines. 2025; 12(12.
PMID: 39767566 PMC: 11726849. DOI: 10.3390/biomedicines12122659.
Non-coding RNAs in oral cancer: Emerging biomarkers and therapeutic frontier.
Hashemi M, Khoushab S, Hobabi Aghmiuni M, Anaraki S, Alimohammadi M, Taheriazam A Heliyon. 2024; 10(21):e40096.
PMID: 39583806 PMC: 11582460. DOI: 10.1016/j.heliyon.2024.e40096.
Discovery of prognostic lncRNAs in colorectal cancer using spatial transcriptomics.
Pinkney H, Ross C, Hodgson T, Pattison S, Diermeier S NPJ Precis Oncol. 2024; 8(1):230.
PMID: 39390212 PMC: 11467462. DOI: 10.1038/s41698-024-00728-1.
Nejat Dehkordi A, Maddahi M, Vafa P, Ebrahimi N, Aref A Clin Transl Oncol. 2024; .
PMID: 39377974 DOI: 10.1007/s12094-024-03742-8.